Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease

Pediatric Pulmonology

Volumn 46, Issue 5, 2011, Pages 497-504

  Pittman, Jessica E ^a   Calloway, Elizabeth H ^a   Kiser, Michelle ^a   Yeatts, John ^a   Davis, Stephanie D ^a   Drumm, Mitchell L ^b   Schechter, Michael S ^c   Leigh, Margaret W ^a   Emond, Mary ^d   Van Rie, Annelies ^e   Knowles, Michael R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e IL   (United States)

Author keywords

epidemiology; infection; lung diseases; obstructive; pediatrics

Indexed keywords

AGE; ARTICLE; BACTERIUM CULTURE; CASE CONTROL STUDY; CHILD; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD; SEX DIFFERENCE; ADOLESCENT; ADULT; INFANT; NEWBORN; ODDS RATIO; PSEUDOMONAS INFECTIONS; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; ODDS RATIO; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79954536467     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21397     Document Type: Article

References (31)

1. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW,. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001; 183: 444-452. (Pubitemid 32105604)
2. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K,. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138: 699-704. (Pubitemid 32417671)
3. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM,. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001; 32: 277-287. (Pubitemid 32938876)
4. Rosenfeld M, Ramsey BW, Gibson RL,. Pseudomonas acquisition in young patients with cystic fibrosis: Pathophysiology, diagnosis, and management. Curr Opin Pulm Med 2003; 9: 492-497. (Pubitemid 37268213)
5. Demko CA, Byard PJ, Davis PB,. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995; 48: 1041-1049.
6. Levy H, Kalish LA, Cannon CL, Garcia KC, Gerard C, Goldmann D, Pier GB, Weiss ST, Colin AA,. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol 2008; 43: 463-471. (Pubitemid 351657313)
7. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ,. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003; 35: 257-262. (Pubitemid 36397675)
8. Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B,. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma-Possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981; 70: 623-628. (Pubitemid 12196513)
9. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC,. The association of socioeconomic status with outcomes in cystic fibrosis patients in the united states. Am J Respir Crit Care Med 2001; 163: 1331-1337. (Pubitemid 32506595)
10. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML,. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005; 293: 581-588. (Pubitemid 40171240)
11. Aebi C, Bracher R, Liechti-Gallati S, Tschappeler H, Rudeberg A, Kraemer R,. The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis-Prognostic significance. Eur J Pediatr 1995; 154: S69-S73.
12. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL,. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91-100. (Pubitemid 34809519)
13. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH,. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997; 100: E2.
14. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA,. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139, 139 e131.
15. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L,. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002; 33: 483-491. (Pubitemid 34547870)
16. Gomez MI, Prince A,. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007; 7: 244-251. (Pubitemid 46731196)
17. Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, Hoo AF, Lum S, Price J, Ranganathan S, Saunders C, Stanojevic S, Stroobant J, Wallis C, Stocks J,. Lung function from infancy to the preschool years following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 42-49. (Pubitemid 351919192)
18. Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW,. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr 2009; 154: 183-188.
19. Pittman JCE, Yeatts J, Drumm M, Leigh MW, Davis SD, Van Rie A, Emond M, Knowles M,. Age of Pseudomonas aeruginosa infection and severity of lung disease in cystic fibrosis adolescents and adults. Pediatr Pulmonol 2008; A332: 319. (Abstracts edition).
20. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR,. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353: 1443-1453. (Pubitemid 41400918)
21. FitzSimmons SC,. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1-9.
22. Rothman K, Greenland S, editors. Modern epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins, 1998.
23. Davis PB,. The gender gap in cystic fibrosis survival. J Gend Specif Med 1999; 2: 47-51.
24. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev KM, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL,. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group. N Engl J Med 1999; 340: 23-30. (Pubitemid 29024680)
25. Proesmans M, Balinska-Miskiewicz W, Dupont L, Bossuyt X, Verhaegen J, Hoiby N, de Boeck K,. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006; 27: 937-943. (Pubitemid 44911106)
26. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM,. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003; 2: 29-34. (Pubitemid 36857407)
27. Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, Cowley E, Hamilton TA, Eidelman DH, Stevenson MM, Radzioch D,. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002; 107: 297-305. (Pubitemid 35356949)
28. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B,. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997; 145: 794-803. (Pubitemid 27188516)
29. Verma N, Bush A, Buchdahl R,. Is there still a gender gap in cystic fibrosis? Chest 2005; 128: 2824-2834. (Pubitemid 41507646)
30. Corey M, Edwards L, Levison H, Knowles M,. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997; 131: 809-814. (Pubitemid 28027602)
31. West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM,. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: Early detection by serology and assessment of risk factors. JAMA 2002; 287: 2958-2967. (Pubitemid 34619999)